Movement Disorder Models
Movement Disorder Models - Related Videos
10:17
An Introduction to Modeling Behavioral Disorders and Stress
0 Views •
2023
Recently, it has been discovered that behavioral conditions such as, depression, anxiety and stress-response have a neurological basis. Understanding the biological underpinnings of these conditions may help scientists in developing more effective therapies to treat these disorders. Typically, rodent models are used in this field and behavioral scientists create these models using interventions like drug administration or surgery. It is important to understand how to create and evaluate rodent...
08:16
Movement Retraining using Real-time Feedback of Performance
0 Views •
Cited by 4 •
2013
Retraining abnormal movement patterns following injury or disease is a key component of physical rehabilitation. Recent advances in technology have permitted accurate assessment of movement during a variety of tasks, with near instantaneous quantification of results. This provides new opportunities for modification of faulty movement patterns in real time.
06:30
Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders
0 Views •
Cited by 119 •
2015
We present an optimized inexpensive and reliable negative geotaxis assay in Drosophila melanogaster as a model for neurodegenerative disorders. Being more sensitive to mild locomotor defects, this assay will help screen for potential genetic interactions and drug targets.
08:06
Eye Movement Monitoring of Memory
0 Views •
Cited by 10 •
2010
Eye movement monitoring (or eye tracking) reveals where in space the eyes linger, when and for how long. Here, we demonstrate how eye tracking can be used to investigate the integrity of memory in multiple participant populations, without requiring verbal, or otherwise explicit, reports.
02:18
Intrinsically Disordered Proteins
0 Views •
2020
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
FAQs
Each model type emphasizes a different level of disease biology. Genetic approaches can reproduce mutation-related features, neurotoxins and lesions alter neural systems, patient-derived cells provide a cellular context, and computational simulations represent activity or signaling in a controlled framework. Comparing these systems helps separate cellular abnormalities from circuit-level and behavioral consequences.
Changes in dopaminergic signaling and basal ganglia circuit activity provide mechanistic links between altered neural function and abnormal movement. Models can therefore be evaluated at several connected levels, from cellular signaling to circuit behavior and measurable motor outcomes. This layered analysis helps researchers determine whether a model reproduces relevant disease mechanisms rather than only a superficial behavioral feature.
Researchers compare which cellular, circuit, and behavioral features each system reproduces, then consider how consistently those features correspond to human disorders. No single model necessarily captures every aspect of Parkinson’s disease, dystonia, or Huntington’s disease. Cross-model comparison identifies strengths and limitations, supporting more cautious interpretation and improving translation from basic neuroscience to clinical research.
Selection depends on the disease mechanism being examined and the level of analysis required. A study may prioritize genetic changes, toxin- or lesion-induced circuit disruption, patient-derived cellular features, computational representation, or measurable motor behavior. Researchers should align the model with the intended question, then assess whether its resulting features support drug, therapy, or biomarker evaluation.
Useful outcomes include cellular changes, altered dopaminergic signaling, basal ganglia circuit activity, and changes in motor behavior. Examining these measures together can show whether an intervention affects an underlying mechanism, a neural circuit, or only the observable movement phenotype. The resulting profile can also help identify candidate biomarkers and distinguish related experimental models.
After a model produces measurable disease-relevant changes, researchers can test candidate drugs or therapies against those outcomes. Improvement in motor behavior may indicate functional benefit, while cellular or circuit measurements can reveal whether the intervention affects the proposed mechanism. Models also provide experimental settings for examining biomarkers before findings are advanced toward clinical research.